Nova Cannabis Inc. (NVACF)

USD 1.26

(-2.77%)

EBITDA Summary of Nova Cannabis Inc.

  • Nova Cannabis Inc.'s latest annual EBITDA in 2023 was 19.05 Million CAD , up 192.33% from previous year.
  • Nova Cannabis Inc.'s latest quarterly EBITDA in 2024 Q2 was 4.83 Million CAD , up 75.24% from previous quarter.
  • Nova Cannabis Inc. reported an annual EBITDA of 3.71 Million CAD in 2022, up 333.71% from previous year.
  • Nova Cannabis Inc. reported an annual EBITDA of -7.32 Million CAD in 2021, up 27.27% from previous year.
  • Nova Cannabis Inc. reported a quarterly EBITDA of 4.48 Million CAD for 2024 Q1, down -37.73% from previous quarter.
  • Nova Cannabis Inc. reported a quarterly EBITDA of 3.26 Million CAD for 2023 Q1, down -56.52% from previous quarter.

Annual EBITDA Chart of Nova Cannabis Inc. (2023 - 2014)

Historical Annual EBITDA of Nova Cannabis Inc. (2023 - 2014)

Year EBITDA EBITDA Growth
2023 19.05 Million CAD 192.33%
2022 3.71 Million CAD 333.71%
2021 -7.32 Million CAD 27.27%
2020 5.53 Million CAD -12.08%
2019 -3.41 Million CAD 76.19%
2018 -8.33 Million CAD 0.0%
2016 -508.14 Thousand CAD -208.41%
2015 -164.76 Thousand CAD -101.0%
2014 -81.97 Thousand CAD 0.0%

Peer EBITDA Comparison of Nova Cannabis Inc.

Name EBITDA EBITDA Difference
Alternative Energy Partners, Inc. -251.11 USD 7586416.754%
Allstar Health Brands, Inc. -241.78 Thousand USD 7978.836%
Beijing Tong Ren Tang Chinese Medicine Company Limited 89.4 Million USD 78.692%
Café Serendipity Holdings, Inc. -1.41 Million USD 1446.008%
Decision Diagnostics Corp. - USD -Infinity%
Health Advance Inc. -47.95 Thousand USD 39822.257%
HealthWarehouse.com, Inc. -1.27 Million USD 1593.758%
LIGAND PHARMACEUTICAL INC 47.23 Million USD 59.667%
MedGen, Inc. -15.37 USD 123942845.608%
Omni Health, Inc. 1.28 Million USD -1379.499%
Oxford Investments Holdings Inc. -343.96 Thousand USD 5638.338%
Pineapple, Inc. -1.47 Million USD 1391.282%
ScripsAmerica, Inc. -3.95 Million USD 581.734%